Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 9
Submit an article Journal homepage
236
Views
1
CrossRef citations to date
0
Altmetric
Review

Recent Advances in the Design and Synthesis of Heterocycles as Anti-Tubercular Agents

Prem M S Chauhan1 Medicinal and Process Chemistry Division, Central Drug Research Institute, CSIR, Lucknow226001Correspondence[email protected]
View further author information
,
Naresh Sunduru1 Medicinal and Process Chemistry Division, Central Drug Research Institute, CSIR, Lucknow226001View further author information
&
Moni Sharma1 Medicinal and Process Chemistry Division, Central Drug Research Institute, CSIR, Lucknow226001View further author information
Pages 1469-1500 | Published online: 13 Sep 2010

Bibliography

  • Ducati RG , Ruffino-NettoA, BassoLA, SantosDS. The resumption of consumption – a review on tuberculosis.Mem. Inst. Oswaldo Cruz101(7), 697–714 (2006).
  • Loddenkemper R , SagebielD, BrendelA. Strategies against multidrug-resistant tuberculosis.Eur. Respir. J.20(36), 66s–77s (2002).
  • Perri GD , BonoraS. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?J. Antimicrob. Chemother.54(3), 593–602 (2004).
  • Bishai WR , ChaissonRE. Short-course chemoprophylaxis for tuberculosis.Clin. Chest Med.18(1), 115–122 (1997).
  • Smith PG , MossAR. Epidemiology of Tuberculosis. In: Tuberculosis: Pathogenesis, Protection, and Control. Bloom B (Ed.). ASM Press, Washington, DC, USA, 47–59 (1994).
  • Hopewell PC . Overview of clinical tuberculosis. In: Tuberculosis: Pathogenesis, Protection, and Control. Bloom B (Ed.), ASM Press, Washington, DC, USA, 25–46 (1994).
  • Snider DE Jr, Raviglione M, Kochi A. Global burden of tuberculosis. In: Tuberculosis: Pathogenesis, Protection, and Control. Bloom B (Ed.), ASM Press, Washington, DC, USA, 3–11 (1994).
  • Bastian I , ColebundersR. Treatment and prevention of multidrug-resistant tuberculosis.Drugs58(4), 633–661 (1999).
  • Barry CE 3rd, Slayden RA, Sampson AE, Lee RE. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem. Pharmacol.59(3), 221–231 (2000).
  • Joshi R , ReingoldAL, MenziesD, PaiM. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.PLoS Med.3(12), 2376–2391 (2006).
  • Rattan A , KaliaA, AhmadN. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Infect. Dis4(2), 195–203 (1998).
  • Gray MA . Tuberculosis drugs.Orthop. Nurs.16(4), 64–69 (1997).
  • Gutierrez-Lugo M -T, Bewley CA. Natural products, small molecules, and genetics in tuberculosis drug development. J. Med. Chem.51(9), 2606–2612 (2008).
  • Janin YL . Antituberculosis drugs: ten years of research.Bioorg. Med. Chem.15, 2479–2513 (2007).
  • Bhowruth V , BrownAK, ReynoldsRCet al. Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 16, 4743–4747 (2006).
  • Pichota A , DuraiswamyJ, YinZet al. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results. Bioorg. Med. Chem. Lett. 18(24), 6568–6572 (2008).
  • Faugeroux V , GenissonY, SalmaY, ConstantP, BaltasaM. Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol.Bioorg. Med. Chem.15(17), 5866–5876 (2007).
  • Kumar RR , PerumalS, SenthilkumarP, YogeeswariP, SriramD. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.Eur. J. Med. Chem.44(9), 3821–3829 (2009).
  • Kumar RR , PerumalS, ManjuSC, BhattP, YogeeswariP, SriramD. An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones.Bioorg. Med. Chem. Lett.19(13), 3461–3465 (2009).
  • Nefzi A , AppelJ, ArutyunyanS, HoughtenRA. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.Bioorg. Med. Chem. Lett.19(17), 5169–5175 (2009).
  • He X , AlianA, StroudR, de Montellano PRO. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J. Med. Chem.49(21), 6308–6323 (2006).
  • Yendapally R , HurdleJG, CarsonEI, LeeRB, LeeRE. N-substituted 3-acetyltetramic acid derivatives as antibacterial agents. J. Med. Chem.51(5), 1487–1491 (2008).
  • Biava M , PorrettaGC, DeiddaD, PompeiR, TafiA, ManettiF. Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.Bioorg. Med. Chem.11(4), 515–520 (2003).
  • Biava M , PorrettaGC, DeiddaD, PompeiR, TafiA, ManettiF. Antimycobacterial compounds. New pyrrole derivatives of BM212.Bioorg. Med. Chem.12(6), 1453–1458 (2004).
  • Biava M , PorrettaGC, PoceGet al. Antimycobacterial compounds. Optimization of the BM212 structure, the lead compound for a new pyrrole derivative class. Bioorg. Med. Chem. 13(4), 1221–1230 (2005).
  • Biava M , PorrettaGC, PoceGet al. 1,5-diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. J. Med. Chem. 51(12), 3644–3648 (2008).
  • Biava M , PorrettaGC, PoceGet al. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. J. Med. Chem. 49(16), 4946–4952 (2006).
  • Biava M , PorrettaGC, PoceGet al. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. Eur. J. Med. Chem. 44(11), 4734–4738 (2009).
  • Ragno R , MarshallGR, SantoRDet al. Antimycobacterial pyrroles: synthesis, anti-mycobacterium tuberculosis activity and QSAR studies. Bioorg. Med. Chem. 8(6), 1423–1432 (2000).
  • Joshi SD , VagdeviHM, VaidyaVP, GadaginamathGS. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents.Eur. J. Med. Chem.43(9), 1989–1996 (2008).
  • Tangallapally RP , YendapallyR, LeeREet al. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents. J. Med. Chem. 47(21), 5276–5283 (2004).
  • Hurdle JG , LeeRB, BudhaNRet al. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents. J. Antimicrob. Chemother. 62(5), 1037–1045 (2008).
  • Tangallapally RP , LeeRB, LenaertsAJ, LeeRE. Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improvedbioavailability.Bioorg. Med. Chem. Lett.16(10), 2584–2589 (2006).
  • Tangallapally RP , YendapallyR, DanielsAJ, LeeRB, LeeRE. Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluation.Curr. Top. Med. Chem.7(5), 509–526 (2007).
  • Tangallapally RP , YendapallyR, LeeRE, LenaertsAJM, LeeRE. Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents.J. Med. Chem.48(26), 8261–8269 (2005).
  • Stephens CE , TaniousF, KimSet al. Diguanidino and ‘reversed’ diamidino 2,5-diarylfurans as antimicrobial agents. J. Med. Chem. 44(11), 1741–1748 (2001).
  • Kücükgüzel SG , RollasS. Synthesis characterization of novel coupling products and 4-aryl hydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents.Farmaco57(7), 583–587 (2002).
  • Sriram D , YogeeswariP, DhaklaP, SenthilkumarP, BanerjeeD, ManjashettyTH. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.Bioorg. Med. Chem. Lett.19(4), 1152–1154 (2009).
  • Rando DG , SatoDN, SiqueiraLet al. Potential tuberculostatic agents. Topliss application on benzoic acid [(5-nitro-thiophen-2-yl)-methylene]-hydrazide series. Bioorg. Med. Chem. 10(3), 557–560 (2002).
  • Lourenco MCS , VicenteFR, HenriquesMGMOet al. Synthesis and biological evaluation of N-(aryl)-2-thiophen-2-ylacetamides series as a new class of antitubercular agents. Bioorg. Med. Chem. Lett. 17(24), 6895–6898 (2007).
  • Senior SJ , IllarionovPA, GurchaSSet al. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. Bioorg. Med. Chem. Lett. 13(21), 3685–3688 (2003).
  • Senior SJ , IllarionovPA, GurchaSSet al. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. Bioorg. Med. Chem. Lett. 14(2), 373–376 (2004).
  • Bhowruth V , BrownAK, SeniorSJ, SnaithJS, BesraGS. Synthesis and biological evaluation of a C5-biphenyl thiolactomycin library.Bioorg. Med. Chem. Lett.17(20), 5643–5646 (2007).
  • Kamal A , ShaikAA, SinhaR, YadavJS, AroraSK. Antitubercular agents. Part 2: new thiolactomycin analogues active against Mycobacterium tuberculosis.Bioorg. Med. Chem. Lett.15(7), 1927–1929 (2005).
  • Balamurugan K , PerumalS, ReddyASK, YogeeswariP, SriramD. A facile domino protocol for the regioselective synthesis and discovery of novel 2-amino-5-arylthieno-[2,3-b]thiophenes as antimycobacterial agents.Tetrahedron Lett.50(45), 6191–6195 (2009).
  • Manetti F , MagnaniM, CastagnoloDet al. Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of Mycobacterium tuberculosis. ChemMedChem 1(9), 973–989 (2006).
  • Castagnolo D , LoguAD, RadiMet al. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. 16(18), 8587–8591 (2008).
  • Castagnolo D , ManettiF, RadiMet al. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Bioorg. Med. Chem. 17(15), 5716–5721 (2009).
  • Mamolo MG , ZampierD, FalagianiV, VioL, BanfiE. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. Farmaco56(8), 593–599 (2001).
  • Ali MA , YarMS. Synthesis and antimycobacterial activity of novel 4-[5-(substitutedphenyl)-1-phenyl-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol derivatives. Med. Chem. Res.15(9), 463–470 (2007).
  • Kini SG , BhatAR, BryantB, WilliamsonJS, DayanFE. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.Eur. J. Med. Chem.44(2), 492–500 (2009).
  • da Silva PEA , RamosaDF, BonacorsoHGet al. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Int. J. Antimicrob. Agents 32(2), 139–144 (2008).
  • Yar MS , SiddiquiAA, AliMA. Synthesis and evaluation of phenoxy acetic acid derivatives as a anti-mycobacterial agents.Bioorg. Med. Chem. Lett.16(17), 4571–4574 (2006).
  • Ali MA , YarMS, SiddiquiAA, HusainA, AbdullahM. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted)phenyl]-3-(4-hydroxy-3-Methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione. Acta Pol. Pharm. Drug Res.63(5), 435–439 (2007).
  • Ali MA , ShaharyarM. Discovery of novel phenoxyacetic acid derivatives as antimycobacterial agents.Bioorg. Med. Chem.15(5), 1896–1902(2007).
  • Stirrett KL , FerrerasJA, JayaprakashV, SinhaBN, RenT, QuadriaLEN. Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis. Bioorg. Med. Chem. Lett.18(8), 2662–2668 (2008).
  • Kücükgüzel SG , RollasS, ErdenizH, KirazM, EkinciAC, VidinA. Synthesis characterisation and pharmacological properties of some 4-aryl hydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines.Eur. J. Med. Chem.35(7–8), 761–771 (2000).
  • Khan A , SarkarS, SarkarD. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Int. J. Antimicrob. Agents32(1), 40–45 (2008).
  • Li X , ManjunathaUH, GoodwinMBet al. Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824. Bioorg. Med. Chem. Lett. 18(7), 2256–2262 (2008).
  • Kim P , ZhangL, ManjunathaUHet al. Structure–activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles. J. Med. Chem. 52(5), 1317–1328 (2009).
  • Kim P , KangS, BoshoffHIet al. Structure–activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure–activity relationships. J. Med. Chem. 52(5), 1329–1344 (2009).
  • Thompson AM , BlaserA, AndersonRFet al. Synthesis, reduction potentials, and antitubercular activity of ring a/b analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3]oxazine (PA-824). J. Med. Chem. 52(3), 637–645 (2009).
  • Chhabria MT , JaniMH. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.Eur. J. Med. Chem.44(10), 3837–3844 (2009).
  • Ozdemir A , Turan-ZitouniG, KaplancikliZA, TunaliY. Synthesis and biological activities of new hydrazide derivatives.J. Enzyme Inhib. Med. Chem.24(3), 825–831 (2009).
  • Zampieri D , MamoloMG, VioLet al. Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method. Bioorg. Med. Chem. 15(23), 7444–7458 (2007).
  • Pandey J , TiwariVK, VermaSSet al. Synthesis and antitubercular screening of imidazole derivatives. Eur. J. Med. Chem. 44(8), 3350–3355 (2009).
  • Sriram D , YogeeswariP, ThirumuruganR, PavanaRK. Discovery of new antitubercular oxazolyl thiosemicarbazones.J. Med. Chem.49(12), 3448–3450 (2006).
  • Sriram D , YogeeswariP, DinakaranM, ThirumuruganR. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother.59(6), 1194–1196 (2007).
  • Mai A , ArticoM, EspositoM, RagnoR, SbardellaG, MassaS. Synthesis and biological evaluation of enantiomerically pure pyrrolyl-oxazolidinones as a new class of potent and selective monoamine oxidase type A inhibitors.Farmaco58(3), 231–241 (2003).
  • Das J , RaoCVL, SastryTVRSet al. Effects of positional and geometrical isomerism on the biological activity of some novel oxazolidinones. Bioorg. Med. Chem. Lett. 15(2), 337–343 (2005).
  • Tangallapally RP , SunD, Rakesh et al. Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorg. Med. Chem. Lett.17(23), 6638–6642 (2007).
  • Rakesh , SunD, LeeRB, TangallapallyRP, LeeRE. Synthesis, optimization and structure–activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents.Eur. J. Med. Chem.44(2), 460–472 (2009).
  • Kini SG , BhatAR, BryantB, WilliamsonJS, DayanFE. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.Eur. J. Med. Chem.44(2), 492–500 (2009).
  • Pieroni M , LilienkampfA, WanB, WangY, FranzblauSG, KozikowskiAP. Synthesis, biological evaluation, and structure–activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. J. Med. Chem.52(20), 6287–6296 (2009).
  • Huang Q , MaoJ, WanBet al. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles. J. Med. Chem. 52(21), 6757–6767 (2009).
  • Turan-Zitouni G , OzdemirA, KaplancikliZA, BenkliK, ChevalletP, AkalinG. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.Eur. J. Med. Chem.43(5), 981–985 (2008).
  • Mallikarjuna BP , SastryBS, KumarGVS, RajendraprasadY, ChandrashekarSM, SathishaK. Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems – a novel class of potential antibacterial, antifungal and antitubercular agents.Eur. J. Med. Chem.44(11), 4739–4746 (2009).
  • Al-Balas Q , AnthonyNG, Al-JaidiBet al. Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the β-ketoacyl-ACP synthase mtFabH. PLoS ONE 4(5), e5617 (2009).
  • de Carvalho LPS , LinG, JiangX, NathanC. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. J. Med. Chem.52(19), 5789–5792 (2009).
  • Japelj B , RecnikS, CebašekP, StanovnikB, SveteJ. Synthesis and antimycobacterial activity of alkyl 1-heteroaryl-1H-1,2,3-triazole-4-carboxylates. J. Heterocycl. Chem.42(6), 1167–1173 (2005).
  • Wilkinson BL , BornaghiLF, WrightAD, HoustonTA, Poulsena S-A. Anti-mycobacterial activity of a bis-sulfonamide. Bioorg. Med. Chem. Lett.17(5), 1355–1357(2007).
  • Gill C , JadhavG, ShaikhMet al. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis. Bioorg. Med. Chem. Lett. 18(23), 6244–6247 (2008).
  • Castagnolo D , RadiM, DessiFet al. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 19(8), 2203–2205 (2009).
  • Kucukguzel I , KucukguzelSG, RollasS, KirazM. Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials.Bioorg. Med. Chem. Lett.11(13), 1703–1707 (2001).
  • Klimešová V , ZahajskáL, WaisserK, KaustováJ, MöllmannU. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.Farmaco59(4), 279–288 (2004).
  • Gülerman NN , DoganHN, RollasS, JohanssonC, CelikC. Synthesis and structure elucidation of some new thioether derivatives of 1,2,4 triazoline -3-thiones and their antimicrobial activity.Farmaco56(12), 953–958 (2001).
  • Shiradkar MR , MurahariKK, GangadasuHRet al. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Bioorg. Med. Chem. 15(12), 3997–4008 (2007).
  • Shiradkar M , KumarGVS, DasariV, TatikondaS, AkulaKC, ShahR. Clubbed triazoles: a novel approach to antitubercular drugs.Eur. J. Med. Chem.42(6), 807–816 (2007).
  • Jadhav GR , ShaikhMU, KaleRP, ShiradkarMR, GillCH. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.Eur. J. Med. Chem.44(7), 2930–2935 (2009).
  • Tyrkov AG , UrlyapovaNG, DaudovaAD. Synthesis and antimycobacterial activity of substituted 2-nitro-1-(4-tolylsulfonyl)-2-(3-methylphenyl-1,2,4-oxadiazol-5-yl)ethanes.Pharmaceut. Chem. J.40(7), 377–379 (2006).
  • Mamolo MG , ZampieriD, VioLet al. Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations. Bioorg. Med. Chem. 13(11), 3797–3809 (2005).
  • Zampieri D , MamoloMG, LauriniEet al. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations. Bioorg. Med. Chem. 17(13), 4693–4707 (2009).
  • Ali MA , ShaharyarM. Oxadiazole mannich bases: synthesis and antimycobacterial activity.Bioorg. Med. Chem. Lett.17(12), 3314–3316 (2007).
  • Foroumadi A , AsadipourA, MirzaeiM, KarimiJ, EmamiS. Antituberculosis agents. V. Synthesis evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4 thiadiazole derivatives. Farmaco57(9), 765–769 (2002).
  • Foroumadi A , MirzaeiM, ShafieeA. Antituberculosis agents II evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4 thiadiazole derivatives. Farmaco56(8), 621–623 (2001).
  • Foroumadi A , KianiZ, SoltaniF. Antituberculosis agents VIII Synthesis and in vitro antimycobacterial activity of alkyl a-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-ylthio]acetates. Farmaco58(11), 1073–1076 (2003).
  • Foroumadi A , MirzaeiM, ShafieeA. Antituberculosis agents: synthesis and antituberculosis activity of 2-aryl-1,3,4 thiadiazole derivatives.Pharmazie56(8), 610–612 (2001).
  • Foroumadi A , KargarZ, SakhtemanAet al. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates. Bioorg. Med. Chem. Lett. 16(5), 1164–1167 (2006).
  • Karakus S , RollasS. Synthesis and antitubercular activity of new N-phenyl-N´- [4-(5-alkyl/aryl amino- 1,3,4- thiadiazole-2-yl) phenyl]thiourea.Farmaco57(7), 577–581 (2002).
  • Mamolo MG , FalgianiV, ZampieriD, VioL, BanfiE. Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl-thio] acetic acid arylidene-hydrazide derivatives.II Farmaco56(8), 587–592 (2001).
  • Mamolo MG , FalagianiV, ZampieriD, VioL, BanfiE, ScialinoG. Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.Farmaco58(9), 631–637 (2003).
  • Oruc EE , RollasS, KandemirliF, ShvetsN, DimogloAS. 1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure–antituberculosis activity relationship investigation.J. Med. Chem.47(27), 6760–6767 (2004).
  • Hearn MJ , WebsterER, CynamonMH. Preparation and properties of antitubercular 1-piperidino-3-arylthioureas.J. Heterocyclic Chem.42(6), 1225–1229 (2005).
  • Weis R , FaistJ, di Vora U et al. Antimycobacterial activity of diphenylpyraline derivatives. Eur. J. Med. Chem.43(4), 872–879 (2008).
  • Weis R , SchweigerK, FaistJet al. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Bioorg. Med. Chem. 16(24), 10326–10331 (2008).
  • Sun D , SchermanMS, JonesVet al. Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity. Bioorg. Med. Chem. 17(10), 3588–3594 (2009).
  • Bogatcheva E , HanrahanC, ChenPet al. Discovery of dipiperidines as new antitubercular agents. Bioorg. Med. Chem. Lett. 20(1), 201–205 (2010).
  • Aridoss G , AmirthaganesanS, KumarNAet al. A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives. Bioorg. Med. Chem. Lett. 18(24), 6542–6548 (2008).
  • Das U , DasS, BandyB, StablesJP, DimmockJR. N-aroyl-3,5-bis(benzylidene)-4-piperidones: a novel class of antimycobacterial agents. Bioorg. Med. Chem.16(7), 3602–3607 (2008).
  • Kumar RR , PerumalS, SenthilkumarP, YogeeswariP, SriramD. Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention.J. Med. Chem.51(18), 5731–5735 (2008).
  • Pagani G , PregnolatoM, UbialiDet al. Synthesis and in vitro anti-Mycobacterium activity of N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation. J. Med. Chem. 43(2), 199–204 (2000).
  • Banfi E , MamoloMG, ZampieriD, VioL, BragadinCM. Antimycobacterial activity of N1-{1-[3-aryl-1-(pyridin-2-, 3- or 4-yl)-3-oxo] propyl}-2-pyridinecarboxamidrazones.J. Antimicrob. Chemother.48(5), 705–707 (2001).
  • Desai B , SurejaD, NaliaparaY, ShahaA, SaxenaAK. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents. Bioorg. Med. Chem.9(8), 1993–1998 (2001).
  • Gezginci MH , MartinAR, FranzblauSG. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2.J. Med. Chem.44(10), 1560–1563 (2001).
  • Maccari R , OttanaR, MonforteF, VigoritaMG. In vitro antimycobacterial activities of 2´-monosubstituted isonicotinohydrazides and their cyanoborane adducts. Antimicrob. Agents Chemother.46(2), 294–299 (2002).
  • Hearn MJ , CynamonMH, ChenMFet al. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid. Eur. J. Med. Chem. 44(10), 4169–4178 (2009).
  • Jaju S , PalkarM, MaddiVet al. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives. Arch. Pharm. Chem. Life Sci. 342(12), 723–731 (2009).
  • Herzigova P , KlimesovsV, PalatK, KaustovaJ, Dahse H-M, Mollmann U. Preparation and in vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents. Arch. Pharm. Chem. Life Sci.342(7), 394–404 (2009).
  • Gaveriya H , DesaiB, VoraV, ShahA. Synthesis of some new unsymmetrical 1,4-dihydropyridine derivatives as potent antitubercular agents.Heterocyclic Commun.5(5), 481–484 (2001).
  • Kharkar PS , DesaiB, GaveriaHet al. Three dimensional quantitative structure–activity relationship of 1,4-dihydropyridines as antitubercular agents. J. Med. Chem. 45(22), 4858–4867 (2002).
  • Khoshneviszadeh M , EdrakiN, JavidniaKet al. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. Bioorg. Med. Chem. 17(4), 1579–1586 (2009).
  • Fassihi A , AzadpourZ, DelbariNet al. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides. Eur. J. Med. Chem. 44(8), 3253–3258 (2009).
  • Lin Y -M, Zhou Y, Flavin MT, Zhou L-M, Nie W, Chen F-C. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg. Med. Chem.10(8), 2795–2802 (2002).
  • Waisser K , DraškováK, KunešJ, KlimešováV, KaustováJ. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides. Farmaco59(8), 615–625 (2004).
  • Sriram D , YogeeswariP, MadhuK. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones. Bioorg. Med. Chem. Lett.15(20), 4502–4505 (2005).
  • Sriram D , YogeeswariP, MadhuK. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl) hydrazono]ethyl}phenyl)thiourea. Bioorg. Med. Chem. Lett.16(4), 876–878 (2006).
  • Carvalho SA , da Silva EF, de Souza MVN, Lourenco MCS, Vicente FR. Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives. Bioorg. Med. Chem. Lett.18(2), 538–541 (2008).
  • Imramovsky A , PolancS, VinsovaJet al. A new modification of anti-tubercular active molecules. Bioorg. Med. Chem. 15(7), 2551–2559 (2007).
  • Lourenco MCS , FerreiraML, de Souza MVN, Peralta MA, Vasconcelos TRA, Henriques MGMO. Synthesis and anti-mycobacterial activity of (E)-N´-(monosubstituted-benzylidene)isonicotinohydrazide derivatives. Eur. J. Med. Chem.43(6), 1344–1347 (2008).
  • Bijev A . New heterocyclic hydrazones in the search for antitubercular agents: synthesis and in vitro evaluations. Lett. Drug Des. Discov.3(7), 506–512 (2006).
  • Kumar A , SinhaS, ChauhanPMS. Synthesis of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions.Bioorg. Med. Chem. Lett.12(4), 667–669 (2002).
  • Agarwal A , SrivastavaK, PuriSK, SinhaS, ChauhanPMS. Solid support synthesis of 6-aryl-2-substituted pyrimidin-4-yl phenols as anti-infective agents.Bioorg. Med. Chem. Lett.15(22), 4923–4926 (2005).
  • Agarwal A , SrivastavaK, PuriSK, SinhaS, ChauhanPMS. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.Bioorg. Med. Chem. Lett.15(23), 5218–5221 (2005).
  • Agarwal N , SrivastavaP, RaghuwanshiSKet al. Upadhyay chloropyrimidines as a new class of antimicrobial agents. Bioorg. Med. Chem. 10(4), 869–874 (2002).
  • Morgan J , HaritakulR, KellerPA. Anilino pyrimidines as novel antituberculosis agents.Bioorg. Med. Chem. Lett.13(10), 1755–1757 (2003).
  • Virsodia V , PissurlenkarRRS, ManvarDet al. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides. Eur. J. Med. Chem. 43(10), 2103–2115 (2008).
  • El-Hamamsy MHRI , SmithAW, ThompsonAS, ThreadgillMD. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis. Bioorg. Med. Chem.15(13), 4552–4576 (2007).
  • Nagaraj A , ReddyCS. Synthesis and biological study of novel methylene-bis-chalcones and substituted methylene-bis-pyrimidines/pyrimidinones J. Heterocycl. Chem.44(5), 1181–1185 (2007).
  • Opletalova V , HartlJ, PatelA, Palat Jr K, Buchta V. Ring substituted 3-phenyl-1-(2 pyrazinyl)-2 propen-1-ones as potential photosynthesis inhibiting, antifungal and antimycobacterial agents. Farmaco57(2), 135–144 (2002).
  • Seitz LE , SulingWJ, ReynoldsRC. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.J. Med. Chem.45(25), 5604–5606 (2002).
  • Krinkova J , DolezalM, HartlJV, BuchtaV, PourM. Synthesis and biological activity of 5-alkyl-6-alkylsulfanyl or 5-alkyl-6-arylsulfanyl pyrazine-2-carboxamides and corresponding thioamides.Farmaco57(1), 71–78 (2002).
  • Foks H , TrapkowskaI, JanowiecM, ZwolskaZ, Augustynowicz-KopecE. Studies on pyrazine derivatives. 38. Synthesis, reactions, and tuberculostatic activity of pyrazinyl-substituted derivatives of hydrazinocarbodithioic acid.Chem. Heterocyclic Compounds40(9), 1185–1193 (2004).
  • Dolezal M , CmedlovaP, PalekLet al. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides. Eur. J. Med. Chem. 43(5), 1105–1113 (2008).
  • He X , AlianA, de Montellano PRO. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorg. Med. Chem.15(21), 6649–6658 (2007).
  • Bogatcheva E , HanrahanC, NikonenkoBet al. Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis. J. Med. Chem. 49(11), 3045–3048 (2006).
  • Zhang X , HuY, ChenSet al. Synthesis and evaluation of (S,S)-N,N´-bis-[3-(2,2´,6,6´-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity. Bioorg. Med. Chem. Lett. 19(21), 6074–6077 (2009).
  • Onajole OK , GovenderK, GovenderPet al. Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents. Eur. J. Med. Chem. 44(11), 4297–4305 (2009).
  • Velikorodov AV , UrlyapovaNG, DaudovaAD. Synthesis and antimycobacterial activity of carbamate derivatives of 1,2-oxazine.Pharmaceut. Chem. J.40(7), 380–382 (2006).
  • Koketsu M , TanakaK, TakenakaY, KwongCD, IshiharaH. Synthesis of 1,3 thiazine derivatives and their evaluation as potential antimycobacterial agents.Eur. J. Pharm. Sci.15(3), 307–310 (2002).
  • Hughes MA , McFaddenJM, TownsendCA. New a-methylene-c-butyrolactones with antimycobacterial properties.Bioorg. Med. Chem. Lett.15(17), 3857–3859 (2005).
  • Cardona W , QuinonesW, RobledoSet al. Antiparasite and antimycobacterial activity of passifloricin analogues. Tetrahedron 62(17), 4086–4092 (2006).
  • Chande MS , VermaRS, BarvePA, KhanwelkarRR, VaidyaRB, AjaikumarKB. Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: a Michael addition approach.Eur. J. Med. Chem.40(11), 1143–1148 (2005).
  • Sonar VN , CrooksPA. Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes.J. Enzyme Inhib. Med. Chem.24(1), 117–124 (2009).
  • Sriram D , YogeeswariP, DhaklaP, SenthilkumarP, BanerjeeD. N-hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity. Bioorg. Med. Chem. Lett.17(7), 1888–1891 (2007).
  • Zampieri D , MamoloMG, LauriniE, ScialinoG, BanfiE, VioL. 2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds-conventional heating in comparison with MW-assisted synthesis.Arch. Pharm. Chem. Life Sci.342(12), 716–722 (2009).
  • Guzel O , MarescaA, ScozzafavaA, SalmanA, BalabanAT, SupuranCT. Discovery of low nanomolar and subnanomolar inhibitors of the Mycobacterial β-carbonic anhydrases Rv1284 and Rv3273. J. Med. Chem.52(13), 4063–4067 (2009).
  • Klimešová V , KocíJ, PourM, StachelJ, WaisserK, KaustováJ. Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.Eur. J. Med. Chem.37(5), 409–418 (2002).
  • Klimešová V , KocíJ, WaisserK, KaustovaJ. New benzimidazole derivatives as antimycobacterial agents.Farmaco57(4), 259–265 (2002).
  • Kazimierczuk Z , AndrzejewskaM, KaustovaJ, KlimešovaV. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.Eur. J. Med. Chem.40(2), 203–208 (2005).
  • Vinsova J , CermakovaK, TomeckovaAet al. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles. Bioorg. Med. Chem. 14(17), 5850–5865 (2006).
  • Koci J , KlimesovaV, WaisserK, KaustovaJ, Dahse H-M, Mollmann U. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity. Bioorg. Med. Chem. Lett.12(22), 3275–3278 (2002).
  • Guzel O , SalmanA. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives. Bioorg. Med. Chem.14(23), 7804–7815 (2006).
  • Konieczny MT , KoniecznyW, SabiszMet al. Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line. Chem. Pharm. Bull. 55(5), 817–820 (2007).
  • Sanna P , CartaA, NikookarMER. Synthesis and antitubercular activity of 3-aryl substituted -2-[(1H(2H) benzotriazol-1(2)-yl] acrylonitrile. Eur. J. Med. Chem.35(5), 535–543 (2000).
  • Sanna P , CartaA, GherardiniL, NikookarMER. Synthesis and antimycobacterial activity of 3 aryl, 3 cyclohexyl and 3-heteroaryl- substituted -2-[1H(2H)-benzotriazol-1(2)-yl) prop-2-enenitriles, prop-2-enamides and propenoic acids II. Farmaco57(1), 79–87 (2002).
  • Bakkestuen AK , GundersenLL, LangliG, LiuF, Nols⊘eJMJ. 9-benzylpurines with inhibitory activity against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett.10(11), 1207–1210 (2000).
  • Gundersen LL , Nissen-MeyerJ, SpilsbergB. Synthesis and antimycobacterial activity of 6-aryl purines: the requirement for the N-9 substituent in active antimycobacterial purines.J. Med. Chem.45(6), 1383–1386 (2002).
  • Scozzafava A , MastrolorenzoA, SupuranCT. Antimycobacterial activity of 9-sulphonylated/sulphenylated -6-mercaptopurine derivatives.Bioorg. Med. Chem. Lett.11(13), 1675–1678 (2001).
  • Bakkestuen AK , Gundersen L-L, Utenova BT. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines. J. Med. Chem.48(7), 2710–2723 (2005).
  • Pathak AK , PathakV, SeitzLE, SulingWJ, ReynoldsRC. Antimycobacterial agents. 1. Thio analogues of purine.J. Med. Chem.47(1), 273–276 (2004).
  • Bakkestuen AK , Gundersen L-L, Petersen D, Utenova BT, Vik A. Synthesis and antimycobacterial activity of agelasine E and analogs. Org. Biomol. Chem.3(6), 1025–1033 (2005).
  • Braendvang M , Gundersen L-L. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines. Bioorg. Med. Chem.15(22), 7144–7165 (2007).
  • Braendvang M , BakkencV, Gundersen L-L. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Bioorg. Med. Chem.17(18), 6512–6516 (2009).
  • Moukha-Chafiq O , TahaML, LazrekHBet al. Synthesis and biological evaluation Of some 4-substituted 1-[1-(4-hydroxybutyl)-1,2,3-triazol-(4&5)-ylmethyl]-1h-pyrazolo-[3,4-d]pyrimidines. Nucleosides Nucleotides Nucleic Acids 20(10&11), 1811–1821 (2001).
  • Moukha-Chafiq O , TahaML, LazrekHB, VasseurJJ, ClercqED. Synthesis and biological evaluation of some acyclic a-(1h-pyrazolo-[3,4-d]pyrimidin-4-yl)thioalkylamide nucleosides.Nucleosides Nucleotides Nucleic Acids21(2), 165–176 (2002)
  • Moukha-Chafiq O , TahaML, MounaA. Synthesis and biological evaluation of some α-[6-(1/-carbamoylalkylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]thioalkylcarboxamide acyclonucleosides.Nucleosides Nucleotides Nucleic Acids26(4), 335–345 (2007).
  • Ballell L , FieldRA, ChungGAC, YoungRJ. New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.Bioorg. Med. Chem. Lett.17(6), 1736–1740 (2007).
  • Zhang Y , JinG, IllarionovB, BacherA, FischerM, CushmanM. A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluation. J. Org. Chem.72(19), 7176–7184 (2007).
  • Chambhare RV , KhadseBG, BobdeAS, BahekarRH. Synthesis and preliminary evaluation of some N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno[2,3-d]pyrimidin-4-ones as antimicrobial agents. Eur. J. Med. Chem.38(1), 89–100 (2003).
  • Jain R , VaitilingamB, NayyarA, PaldePB. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.Bioorg. Med. Chem. Lett.13(6), 1051–1054 (2003).
  • Gaurrand S , DesjardinsS, MeyerCet al. Conformational analysis of R207910, a new drug candidate for the treatment of tuberculosis, by a combined NMR and molecular modeling approach. Chem. Biol. Drug Des. 68(2), 77–84 (2006).
  • Drews SJ , HungF, Av-GayY. A protein kinase inhibitor as an antimycobacterial agent.FEMS Microbiol. Lett.205(2), 369–374 (2001).
  • Savini L , ChiasseriniL, GaetaA, PelleranoC. Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones.Bioorg. Med. Chem.10(7), 2193–2198 (2002).
  • Monga V , NayyarA, VaitilingamBet al. Ring-substituted quinolines. Part 2: synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues. Bioorg. Med. Chem. 12(24), 6465–6472 (2004).
  • de Souza MVN , PaisKC, KaiserCR, PeraltaMA, FerreiraML, LourençoMCS. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.Bioorg. Med. Chem.17(4), 1474–1480 (2009).
  • Upadhayaya RS , VandavasiJK, VasireddyNR, SharmaV, DixitSS, ChattopadhyayaJ. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis. Bioorg. Med. Chem.17(11), 2830–2841 (2009).
  • Sharma M , ChaturvediV, ManjuYKet al. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur. J. Med. Chem. 44(5), 2081–2091 (2009).
  • Gratraud P , SuroliaN, BesraGS, SuroliaA, KremerL. Antimycobacterial activity and mechanism of action of NAS-91.Antimicrob. Agents Chemother.52(3), 1162–1166 (2008).
  • Eswaran S , AdhikariAV, PalNK, ChowdhuryIH. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents.Bioorg. Med. Chem. Lett.20(3), 1040–1044 (2010).
  • Gemma S , SaviniL, AltarelliMet al. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure–activity relationship studies. Bioorg. Med. Chem. 17(16), 6063–6072 (2009).
  • Candéa ALP , FerreiraML, PaisKCet al. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg. Med. Chem. Lett. 19(22), 6272–6274 (2009).
  • Upadhayaya RS , KulkarniGM, VasireddyNRet al. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis. Bioorg. Med. Chem. 17(13), 4681–4692 (2009).
  • Nayyar A , PatelSR, ShaikhM, CoutinhoE, JainR. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines.Eur. J. Med. Chem.44(5), 2017–2029 (2009).
  • Lilienkampf A , MaoJ, WanB, WangY, FranzblauSG, KozikowskiAP. Structure–activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. J. Med. Chem.52(7), 2109–2118 (2009).
  • Mao J , YuanH, WangYet al. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters. J. Med. Chem. 52(22), 6966–6978 (2009).
  • Carta A , PagliettiG, NikookarMER, SannaP, SechiL, ZanettiS. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity. Eur. J. Med. Chem.37(5), 355–366 (2002).
  • Carta A , LorigaM, PagliettiGet al. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides. Eur. J. Med. Chem. 39(2), 195–203 (2004).
  • Zarranz B , JasoA, AldanaI, MongeA. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Bioorg. Med. Chem.11(10), 2149–2156 (2003).
  • Jaso A , ZarranzB, AldanaI, MongeA. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as antimycobacterium tuberculosis agents. Eur. J. Med. Chem.38(9), 791–800 (2003).
  • Villar R , VicenteE, SolanoB et al. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. J. Antimicrob. Chemother.62(3), 547–554 (2008).
  • Jaso A , ZarranzB, AldanaI, MongeA. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as antimycobacterium tuberculosis agents.J. Med. Chem.48(6), 2019–2025 (2005).
  • Vicente E , Perez-SilanesS, LimaLMet al. Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides. Bioorg. Med. Chem. 17(1), 385–389 (2009).
  • Sheu J -Y, Chen Y-L, Tzeng C-C, Hsu S-L, Fang K-C, Wang T-C. Synthesis, and antimycobacterial and cytotoxic evaluation of certain fluoroquinolone derivatives. Helv. Chim. Acta86(7), 2481–2489 (2003).
  • Senthilkumar P , DinakaranM, YogeeswariP, ChinaA, NagarajaV, SriramD. Antimycobacterial activities of novel fluoroquinolones.Biomedicine Pharmacother.63(1), 27–35 (2009).
  • Kawakami K , NambaK, TanakaM, MatsuhashiN, SatoK, TakemuraM. Antimycobacterial activities of novel levofloxacin analogues.Antimicrob. Agents Chemother.44(8), 2126–2129 (2000).
  • Alcaide F , CalatayudL, SantínM, MartínR. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrob. Agents Chemother.48(12), 4562–4565 (2004).
  • Sriram D , YogeeswariP, GopalG. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.Eur. J. Med. Chem.40(12), 1373–1376 (2005).
  • Sriram D , YogeeswariP, BashaJS, RadhaDR, NagarajaV. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.Bioorg. Med. Chem.13(20), 5774–5778 (2005).
  • Sriram D , AubryA, YogeeswariP, FisherLM. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.Bioorg. Med. Chem. Lett.16(11), 2982–2985 (2006).
  • Sriram D , YogeeswariP, DevakaramRV. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg. Med. Chem.14(9), 3113–3118 (2006).
  • Talatha S , GadadAK. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives.Eur. J. Med. Chem.41(8), 918–924 (2006).
  • Arya K , AgarwalM. Microwave prompted multigram synthesis, structural determination, and photo-antiproliferative activity of fluorinated 4-hydroxyquinolinones.Bioorg. Med. Chem. Lett.17(1), 86–93 (2007).
  • Ukrainets IV , MospanovaEV, SidorenkoLV. 4-Hydroxy-2-quinolones. 122. 1-hydroxy-3-oxo-5,6-dihydro-3h-pyrrolo[3,2,1-ij]-quinoline-2-carboxylic acid hetarylamides as potential antitubercular agents. Chem. Heterocycl. Comp.43(7), 863–870 (2007).
  • Dinakaran M , SenthilkumarP, YogeeswariP, ChinaA, NagarajaVM, SriramD. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5, 12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.Bioorg. Med. Chem.16(6), 3408–3418 (2008).
  • Senthilkumar P , DinakaranM, YogeeswariP, SriramD, ChinaA, NagarajaV. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.Eur. J. Med. Chem.44(1), 345–358 (2009).
  • Carta A , PalombaM, PagliettiGet al. [1,2,3] triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains. Bioorg. Med. Chem. Lett. 17(17), 4791–4794 (2007).
  • Carta A , PirasS, PalombaM, JabesD, MolicottiP, ZanettiS. Anti-mycobacterial activity of quinolones. Triazoloquinolones a new class of potent anti-mycobacterial agents.Anti-Infective Agents in Med. Chem.7(2), 134–147 (2008).
  • Dinakaran M , SenthilkumarP, YogeeswariP, ChinaA, NagarajaV, SriramD. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.Bioorg. Med. Chem. Lett.18(3), 1229–1236 (2008).
  • Senthilkumar P , DinakaranM, BanerjeeDet al. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. Bioorg. Med. Chem. 16(5), 2558–2569 (2008).
  • Dinakaran M , SenthilkumarP, YogeeswariP, ChinaA, NagarajaV, SriramD. Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. Int. J. Antimicrob. Agents31(4), 337–344 (2008).
  • Senthilkumar P , DinakaranM, ChandraseakaranY, YogeeswariP, SriramD. Synthesis and in vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro-8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids. Arch. Pharm. Chem. Life Sci.342(2), 100–112 (2009).
  • Senthilkumar P , DinakaranM, YogeeswariP, ChinaA, NagarajaV, SriramD. Antimycobacterial activities of novel fluoroquinolones.Biomed. Pharmacother.63(1), 27–35 (2009).
  • de Almeida MV , SaraivaMF, de Souza MVN, da Costa CF, Vicente FRC, Lourenco MCS. Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives. Bioorg. Med. Chem. Lett.17(20), 5661–5664 (2007).
  • Sriram D , YogeeswariP, SenchaniG, BanerjeeD. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.Bioorg. Med. Chem. Lett.17(8), 2372–2375 (2007).
  • Andreani A , GranaiolaM, LeoniA, LocatelliA, MorigiR, RambaldiM. Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles. Eur. J. Med. Chem.36(9), 743–746 (2001).
  • Kolavi G , HegdeV, KhaziaIA, GadadP. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.Bioorg. Med. Chem.14(9), 3069–3080 (2006).
  • Zwawiak J , OlenderD, ZwolskaZ, Augustynowicz-KopecE, ZaprutkoL. Synthesis of 2,3-dihydro-7-nitroimidazo[5,1-b]oxazoles as potential tuberculostatic agents.Acta Poloniae Pharmaceutica-Drug Research,65(2), 229–233 (2008).
  • Kamal A , ReddyKS, AhmedSKet al. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Bioorg. Med. Chem. 14(3), 650–658 (2006).
  • Kamal A , AhmedSK, ReddyKSet al. Anti-tubercular agents. Part IV: synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines. Bioorg. Med. Chem. Lett. 17(19), 5419–5422 (2007).
  • Kumar RR , PerumalS, SenthilkumarP, YogeeswariP, SriramD. An atom efficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(E)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano[3,2-c]pyridine-3-carbonitriles. Bioorg. Med. Chem. Lett.17(23), 6459–6462 (2007).
  • Tripathi RP , VermaSS, PandeyJet al. Search of antitubercular activities in tetrahydroacridines: synthesis and biological evaluation. Bioorg. Med. Chem. Lett. 16(19), 5144–5147 (2006).
  • Reddy VM , O‘SullivanJF, GangadharamPR. Antimycobaterial activites of riminophenazines.J. Antimicrob. Chemother.43(5), 615–623 (1999).
  • Matlola NM , SteelHC, AndersonR. Antimycobacterial action of B4128, a novel tetramethylpiperidyl-substituted phenazine.J. Antimicrob. Chemother.47(2), 199–202 (2001).
  • Kamal A , BabuAH, RamanaAV, SinhaR, YadavJS, AroraSK. Antitubercular agents. Part 1: Synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents.Bioorg. Med. Chem. Lett.15(7), 1923–1926 (2005).
  • De Logu A , PalchykovskaLH, KostinaVHet al. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 33(3), 223–229 (2009).
  • Madrid PB , PolgarWE, TollL, TangaaMJ. Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors.Bioorg. Med. Chem. Lett.17(11), 3014–3017 (2007).
  • Bate AB , KalinJH, FooksmanEMet al. Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives. Bioorg. Med. Chem. Lett. 17(5), 1346–1348 (2007).
  • Silva RSF , PintoMCFR, GoulartMOFet al. A macrolactone from benzo[a]phenazine with potent activity against Mycobacterium tuberculosis. Eur. J. Med. Chem. 44(5), 2334–2337 (2009).
  • Velezheva VS , BrennanPJ, MarshakovVYet al. Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidase. J. Med. Chem. 47(13). 3455–3461 (2004).
  • Karthikeyan SV , PerumalS, ShettyKA, YogeeswariP, SriramD. A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.Bioorg. Med. Chem. Lett.19(11), 3006–3009 (2009).
  • Guillon J , ReynoldsRC, Leger J-M et al. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives. J. Enz. Inhib. Med. Chem.19(6), 489–495 (2004).
  • Scozzafava A , MastrolorenzoA, SupuranCT. Antimycobacterial activity of 3,4-dichlorophenyl-ureas, N,N-diphenyl-ureas and related derivatives. J. Enzyme Inhib.16(3), 425–432 (2001).
  • Copp BR , ChristiansenHC, LindsayBS, FranzblauSG. Identification of heteroarylenamines as a new class of antituberculosis lead molecules.Bioorg. Med. Chem. Lett.15(18), 4097–4099 (2005).
  • Prado S , LedeitH, MichelSet al. Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. Bioorg. Med. Chem. 14(15), 5423–5428 (2006).
  • Prado S , JaninYL, Saint-JoanisBet al. Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. Bioorg. Med. Chem. 15(5), 2177–2186 (2007).
  • Alvey L , PradoS, HuteauVet al. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial. Bioorg. Med. Chem. 16(17), 8264–8272 (2008).
  • Alvey L , PradoS, Saint-JoanisBet al. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity. Eur. J. Med. Chem. 44(6), 2497–2505 (2009).
  • Xu Z -Q, Pupek K, Suling WJ, Enache L, Flavin MT. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis. Bioorg. Med. Chem.14(13), 4610–4626 (2006).
  • Hotoda H , FurukawaM, DaigoMet al. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin. Bioorg. Med. Chem. Lett. 13(17), 2829–2832 (2003).
  • Hotoda H , DaigoM, FurukawaMet al. Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds. Bioorg. Med. Chem. Lett. 13(17), 2833–2836 (2003).
  • AM Ende CW , KnudsonSE, LiuNet al. Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors. Bioorg. Med. Chem. Lett. 18(10), 3029–3033 (2008).
  • Jean L , SantosJL, YamasakiPRet al. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives. Bioorg. Med. Chem. 17(11), 3795–3799 (2009).
  • Parai MK , PandaG, ChaturvediV, ManjuYK, SinhaS. Thiophene containing triarylmethanes as antitubercular agents.Bioorg. Med. Chem. Lett.18(1), 289–292 (2008).
  • Panda G , ParaiMK, DasSKet al. Effect of substituents on diarylmethanes for antitubercular activity. Eur. J. Med. Chem. 42(3), 410–419 (2007).
  • Karthikeyan SV , BalaBD, RajaVPA, PerumalS, YogeeswariP, SriramD. A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents.Bioorg. Med. Chem. Lett.20(1), 350–353 (2010).
  • Raparti V , ChitreT, BotharaKet al. Novel 4-(morpholin-4-yl)-N´- (arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations. Eur. J. Med. Chem. 44(10), 3954–3960 (2009).
  • Odell LR , NilssonMT, GisingJet al. Functionalized 3-amino-imidazo[1,2- a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Bioorg. Med. Chem. Lett. 19(16), 4790–4793 (2009).
  • Figueiredo R , MoiteiroC, MedeirosMAet al. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis. Bioorg. Med. Chem. 17(2), 503–511 (2009).
  • Guo S , SongY, HuangQet al. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents. J. Med. Chem. 53(2), 649–659 (2010).
  • Makarov V , ManinaG, MikusovaKet al. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324(5928), 801–804 (2009).
  • Abdel-Rahman HM , El-KoussiNA, HassanHY. Fluorinated 1,2,4-triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.Arch. Pharm. Chem. Life Sci.342(2), 94–99 (2009).
  • Maddry JA , AnanthanS, GoldmanRCet al. Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis. 89(5), 354– 363 (2009).
  • Ananthan S , FaaleoleaER, GoldmanRCet al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 89(5), 334–353 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.